Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-07-31
1991-11-12
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514473, 549265, 549331, 549343, A61K 31365, C07D30794
Patent
active
050648560
ABSTRACT:
Compound of formulae (I) and (II) are HMG-CoA synthase inhibitors and exhibit antifungal activity. ##STR1##
REFERENCES:
patent: 4751237 (1988-06-01), Chabala et al.
patent: 4806564 (1989-02-01), Chabala et al.
patent: 4816477 (1989-03-01), Girotra et al.
patent: 4847271 (1989-07-01), Chabala et al.
H. W. Fehlaker et al., J. Am. Chem. Soc., 110, 8242-8244 (1988).
DT 2821-189, 11-23-78, Japan.
Del Val Sagrario M.
Garrity George M.
Giacobbe Robert
Greenspan Michael D.
Hensens Otto D.
DiPrima Joseph F.
Ivy C. Warren
Merck & Co. , Inc.
Trinh Ba K.
Winokur Melvin
LandOfFree
Novel HMG-CoA synthase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel HMG-CoA synthase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel HMG-CoA synthase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1013456